This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: R Lokey - Innovator in Molecular Scaffolds
Introduction
R Lokey is a prominent inventor based in Santa Cruz, California. He has made significant contributions to the field of molecular scaffolds, particularly through his innovative work on peptide-peptoid scaffolds. His research focuses on creating molecular structures that exhibit high cell permeability, which can have profound implications in various scientific applications.
Latest Patents
R Lokey holds a patent for peptide-peptoid scaffolds, which are molecular scaffolds that include cyclic peptides. This invention is notable for its ability to achieve large cell permeability, making it a valuable asset in the realm of molecular biology and drug development. He has 1 patent to his name, showcasing his expertise and innovative spirit.
Career Highlights
R Lokey is affiliated with the University of California, where he continues to advance his research in molecular scaffolds. His work has garnered attention for its potential applications in enhancing drug delivery systems and improving therapeutic outcomes. His dedication to research and innovation has established him as a key figure in his field.
Collaborations
R Lokey collaborates with Akihiro Furukawa, further enriching his research endeavors. Their combined expertise contributes to the advancement of knowledge in molecular scaffolds and their applications.
Conclusion
R Lokey's contributions to the field of molecular scaffolds exemplify the impact of innovative research on science and technology. His work continues to inspire future advancements in drug delivery and molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
